Gossamer Bio, Inc. (GOSS)
10.97
-0.27
(-2.40%)
USD |
NASDAQ |
Nov 13, 16:00
10.92
-0.05
(-0.46%)
After-Hours: 19:59
Gossamer Bio Shareholders Equity (Quarterly) : -122.80M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -122.80M |
| June 30, 2026 | -94.03M |
| March 31, 2026 | -161.48M |
| December 31, 2025 | -122.76M |
| September 30, 2025 | -82.33M |
| June 30, 2025 | -46.11M |
| March 31, 2025 | -6.25M |
| December 31, 2024 | 29.49M |
| September 30, 2024 | 54.14M |
| June 30, 2024 | 81.53M |
| March 31, 2024 | 26.72M |
| December 31, 2023 | 62.77M |
| September 30, 2023 | 104.62M |
| June 30, 2023 | -62.80M |
| March 31, 2023 | -28.46M |
| December 31, 2022 | 12.08M |
| September 30, 2022 | 56.35M |
| June 30, 2022 | -16.46M |
| Date | Value |
|---|---|
| March 31, 2022 | 30.16M |
| December 31, 2021 | 121.46M |
| September 30, 2021 | 169.81M |
| June 30, 2021 | 220.69M |
| March 31, 2021 | 272.08M |
| December 31, 2020 | 320.68M |
| September 30, 2020 | 372.10M |
| June 30, 2020 | 420.32M |
| March 31, 2020 | 306.46M |
| December 31, 2019 | 352.48M |
| September 30, 2019 | 398.87M |
| June 30, 2019 | 441.44M |
| March 31, 2019 | 480.26M |
| December 31, 2018 | 218.30M |
| September 30, 2018 | 246.59M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -6.862M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| United Therapeutics Corp. | 6.276B |
| Arbutus Biopharma Corp. | 85.75M |
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 64.34M |
| Total Liabilities (Quarterly) | 187.13M |
| Debt to Equity Ratio | -0.3327 |
| Current Ratio | 0.6046 |
| Net Debt Paydown Yield | 44.70% |